Skip to main content

Curated Wealth Partners LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1781284 EL SEGUNDO, CA

Position in NBIX

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$8,041,886
+$7,672,790 QoQ
Shares Held
47,715
+1664.6% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#7
of 84 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Derivatives in NBIX

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
0
PutValue
$368,383
PutShares
2,671

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Curated Wealth Partners LLC holds $39,127,348 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (20.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
47,715 $8,041,886

All Filings in NBIX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,041,886 47,715
2024-12-31 $369,096 2,704
2024-09-30 $307,752 2,671
2024-06-30 $367,716 2,671
2024-03-31 $368,383 2,671
2023-12-31 $374,330 2,841
2023-09-30 $295,537 2,627